Comparison of the effectiveness of awake-prone positioning and high-flow nasal oxygen in patients with COVID-19-related acute respiratory failure between different waves
- PMID: 39442133
- PMCID: PMC11484112
- DOI: 10.62675/2965-2774.20240065-en
Comparison of the effectiveness of awake-prone positioning and high-flow nasal oxygen in patients with COVID-19-related acute respiratory failure between different waves
Abstract
Objective: To compare the effectiveness of the awake-prone position on relevant clinical outcomes in patients with COVID-19-related acute respiratory failure requiring high-flow nasal oxygen between different waves in Argentina.
Methods: This multicenter, prospective cohort study included adult patients with COVID-19-related acute respiratory failure requiring high-flow nasal oxygen. The main exposure position was the awake-prone position (≥ 6 hours/day) compared to the non-prone position. The primary outcome was endotracheal intubation, and the secondary outcome was in-hospital mortality. The inverse probability weighting-propensity score was used to adjust the conditional probability of treatment assignment. We then adjusted for contextual variables that varied over time and compared the effectiveness between the first and second waves.
Results: A total of 728 patients were included: 360 during the first wave and 368 during the second wave, of whom 195 (54%) and 227 (62%) remained awake-prone for a median (p25 - 75) of 12 (10 - 16) and 14 (8 - 17) hours/day, respectively (Awake-Prone Position Group). The ORs (95%CIs) for endotracheal intubation in the Awake-Prone Position Group were 0.25 (0.13 - 0.46) and 0.19 (0.09 - 0.31) for the first and second waves, respectively (p = 0.41 for comparison between waves). The ORs for in-hospital mortality in the awake-prone position were 0.35 (0.17 - 0.65) and 0.22 (0.12 - 0.43), respectively (p = 0.44 for comparison between waves).
Conclusion: The awake-prone position was associated with a reduction in the risk of endotracheal intubation and in-hospital mortality. These effects were independent of the context in which the intervention was applied, and no differences were observed between the different waves.
Objetivo:: Comparar a eficácia da posição prona consciente nos desfechos clínicos relevantes em pacientes com insuficiência respiratória aguda relacionada à COVID-19 que necessitaram de oxigênio nasal de alto fluxo em diferentes ondas da doença na Argentina.
Métodos:: Trata-se de estudo de coorte prospectivo e multicêntrico, que incluiu pacientes adultos com insuficiência respiratória aguda relacionada à COVID-19 que necessitaram de oxigênio nasal de alto fluxo. A principal posição de exposição foi a prona consciente (≥ 6 horas/dia) em comparação com a prona não consciente. O desfecho primário foi a intubação endotraqueal, e o secundário foi a mortalidade hospitalar. Utilizou-se o escore de propensão de ponderação pela probabilidade inversa para ajustar a probabilidade condicional de atribuição de tratamento. Em seguida, ajustamos as variáveis contextuais, que variaram ao longo do tempo e comparamos a eficácia entre a primeira e a segunda onda.
Resultados:: Ao todo, 728 pacientes foram incluídos: 360 durante a primeira onda e 368 durante a segunda onda, dos quais 195 (54%) e 227 (62%) permaneceram em prona consciente numa mediana (intervalo interquatil 25 - 75%) de 12 (10 - 16) e 14 (8 - 17) horas/dia, respectivamente (Grupo Prona Consciente). As razões de chance (intervalo de confiança de 95%) de intubação endotraqueal no grupo prona em vigília foram de 0,25 (0,13 - 0,46) e 0,19 (0,09 - 0,31) na primeira e segunda ondas, respectivamente (p = 0,41 comparativamente entre as ondas). As razões de chance de mortalidade intra-hospitalar na posição prona consciente foram de 0,35 (0,17 - 0,65) e 0,22 (0,12 - 0,43), respectivamente (p = 0,44 comparativamente entre as ondas).
Conclusão:: A posição prona consciente foi associada à redução no risco de intubação endotraqueal e mortalidade hospitalar. Esses efeitos foram independentes do contexto em que a intervenção foi aplicada e não foram observadas diferenças entre as diferentes ondas.
Conflict of interest statement
Figures
Similar articles
-
Impact of exposure time in awake prone positioning on clinical outcomes of patients with COVID-19-related acute respiratory failure treated with high-flow nasal oxygen: a multicenter cohort study.Crit Care. 2022 Jan 7;26(1):16. doi: 10.1186/s13054-021-03881-2. Crit Care. 2022. PMID: 34996496 Free PMC article.
-
Awake prone positioning in patients with hypoxemic respiratory failure due to COVID-19: the PROFLO multicenter randomized clinical trial.Crit Care. 2021 Jun 14;25(1):209. doi: 10.1186/s13054-021-03602-9. Crit Care. 2021. PMID: 34127046 Free PMC article. Clinical Trial.
-
Hypoxaemic respiratory failure and awake prone ventilation (HYPER-AP) - Protocol for randomized, controlled clinical trial.Contemp Clin Trials. 2024 Oct;145:107614. doi: 10.1016/j.cct.2024.107614. Epub 2024 Jun 28. Contemp Clin Trials. 2024. PMID: 38945293
-
Effect of Awake Prone Positioning in non-Intubated COVID-19 Patients with Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-Analysis.J Intensive Care Med. 2022 Nov;37(11):1493-1503. doi: 10.1177/08850666221121593. Epub 2022 Aug 25. J Intensive Care Med. 2022. PMID: 36017576 Free PMC article. Review.
-
High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure.Chest. 2020 Nov;158(5):1992-2002. doi: 10.1016/j.chest.2020.07.013. Epub 2020 Jul 15. Chest. 2020. PMID: 32681847 Free PMC article. Review.
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. - PubMed
-
- Reyes LF, Murthy S, Garcia-Gallo E, Merson L, Ibáñez-Prada ED, Rello J, Fuentes YV, Martin-Loeches I, Bozza F, Duque S, Taccone FS, Fowler RA, Kartsonaki C, Gonçalves BP, Citarella BW, Aryal D, Burhan E, Cummings MJ, Delmas C, Diaz R, Figueiredo-Mello C, Hashmi M, Panda PK, Jiménez MP, Rincon DFB, Thomson D, Nichol A, Marshall JC, Olliaro PL, ISARIC Characterization Group Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study. Crit Care. 2022;26(1):276–276. - PMC - PubMed
-
- Ehrmann S, Li J, Ibarra-Estrada M, Perez Y, Pavlov I, McNicholas B, Roca O, Mirza S, Vines D, Garcia-Salcido R, Aguirre-Avalos G, Trump MW, Nay MA, Dellamonica J, Nseir S, Mogri I, Cosgrave D, Jayaraman D, Masclans JR, Laffey JG, Tavernier E, Awake Prone Positioning Meta-Trial Group Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021;9(12):1387–1395. - PMC - PubMed
-
- Li J, Luo J, Pavlov I, Perez Y, Tan W, Roca O, Tavernier E, Kharat A, McNicholas B, Ibarra-Estrada M, Vines DL, Bosch NA, Rampon G, Simpson SQ, Walkey AJ, Fralick M, Verma A, Razak F, Harris T, Laffey JG, Guerin C, Ehrmann S, Awake Prone Positioning Meta-Analysis Group Awake prone positioning for non-intubated patients with COVID-19-related acute hypoxaemic respiratory failure: a systematic review and meta-analysis. Lancet Respir Med. 2022;10(6):573–583. - PMC - PubMed
-
- Greco M, De Corte T, Ercole A, Antonelli M, Azoulay E, Citerio G, Morris AC, De Pascale G, Duska F, Elbers P, Einav S, Forni L, Galarza L, Girbes ARJ, Grasselli G, Gusarov V, Jubb A, Kesecioglu J, Lavinio A, Delgado MCM, Mellinghoff J, Myatra SN, Ostermann M, Pellegrini M, Povoa P, Schaller SJ, Teboul JL, Wong A, De Waele JJ, Cecconi M, ESICM UNITE-COVID investigators Clinical and organizational factors associated with mortality during the peak of first COVID-19 wave: the global UNITE-COVID study. Intensive Care Med. 2022;48(6):690–705. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical